ASCO’s Board of Directors approved the launch of a new online-only precision oncology journal. This bimonthly journal will publish research from histology-based, biomarker-integrated clinical trials. In addition, the journal will present case reports that are evidence- and mechanism-based and focus on the experiences of a single patient. The journal will include editorials, reviews, commentaries, and research addressing key issues unique to precision oncology.